Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

HKG:2637 Statistics

Total Valuation

HKG:2637 has a market cap or net worth of HKD 10.74 billion. The enterprise value is 10.46 billion.

Market Cap	10.74B
Enterprise Value	10.46B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

HKG:2637 has 78.71 million shares outstanding.

Current Share Class	78.71M
Shares Outstanding	78.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.80%
Owned by Institutions (%)	6.04%
Float	14.27M

Valuation Ratios

The trailing PE ratio is 63.35.

PE Ratio	63.35
Forward PE	n/a
PS Ratio	21.63
PB Ratio	18.65
P/TBV Ratio	18.65
P/FCF Ratio	n/a
P/OCF Ratio	61.58
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 71.22, with an EV/FCF ratio of -672.31.

EV / Earnings	72.23
EV / Sales	21.06
EV / EBITDA	71.22
EV / EBIT	73.88
EV / FCF	-672.31

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.11.

Current Ratio	1.90
Quick Ratio	1.71
Debt / Equity	0.11
Debt / EBITDA	0.41
Debt / FCF	-3.89
Interest Coverage	18.42

Financial Efficiency

Return on equity (ROE) is 28.75% and return on invested capital (ROIC) is 48.05%.

Return on Equity (ROE)	28.75%
Return on Assets (ROA)	12.62%
Return on Invested Capital (ROIC)	48.05%
Return on Capital Employed (ROCE)	23.19%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.03M
Profits Per Employee	882,997
Employee Count	164
Asset Turnover	0.71
Inventory Turnover	2.64

Taxes

In the past 12 months, HKG:2637 has paid 13.74 million in taxes.

Income Tax	13.74M
Effective Tax Rate	8.67%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	138.99
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.28
Average Volume (20 Days)	57,650

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2637 had revenue of HKD 496.63 million and earned 144.81 million in profits. Earnings per share was 2.15.

Revenue	496.63M
Gross Profit	412.04M
Operating Income	141.56M
Pretax Income	158.56M
Net Income	144.81M
EBITDA	144.68M
EBIT	141.56M
Earnings Per Share (EPS)	2.15

Balance Sheet

The company has 290.77 million in cash and 60.53 million in debt, with a net cash position of 230.24 million or 2.93 per share.

Cash & Cash Equivalents	290.77M
Total Debt	60.53M
Net Cash	230.24M
Net Cash Per Share	2.93
Equity (Book Value)	576.07M
Book Value Per Share	8.57
Working Capital	174.72M

Cash Flow

In the last 12 months, operating cash flow was 174.46 million and capital expenditures -190.02 million, giving a free cash flow of -15.56 million.

Operating Cash Flow	174.46M
Capital Expenditures	-190.02M
Free Cash Flow	-15.56M
FCF Per Share	-0.20

Margins

Gross margin is 82.97%, with operating and profit margins of 28.50% and 29.16%.

Gross Margin	82.97%
Operating Margin	28.50%
Pretax Margin	31.93%
Profit Margin	29.16%
EBITDA Margin	29.13%
EBIT Margin	28.50%
FCF Margin	n/a

Dividends & Yields

HKG:2637 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.35%
FCF Yield	-0.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2637 has an Altman Z-Score of 1.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.93
Piotroski F-Score	4